Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05722418 |
|---|---|
| Brief Title: | CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (CaMMouflage) |
| First Submitted : | December 19, 2022 |
| First Submitted that Met QC Criteria : | February 2, 2023 |
| First Posted : | February 10, 2023 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 6, 2024 |